{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amoxicillin-Clavulanate%2C+5+days", "query": { "intervention": "Amoxicillin-Clavulanate, 5 days" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amoxicillin-Clavulanate%2C+5+days&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T01:16:44.869Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05584657", "title": "Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infections", "Cystitis" ], "interventions": [ { "name": "Sulopenem etzadroxil/probenecid", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 2229, "start_date": "2022-10-18", "completion_date": "2023-11-21", "has_results": true, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 167, "location_summary": "Cullman, Alabama • Saraland, Alabama • Sheffield, Alabama + 126 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Saraland", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05584657" }, { "nct_id": "NCT07648290", "title": "Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Overactive Bladder" ], "interventions": [ { "name": "Macrobid® Capsules 100 mg", "type": "DRUG" }, { "name": "Standard Medical Care (SMC)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 260, "start_date": "2026-07-31", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07648290" }, { "nct_id": "NCT02927834", "title": "Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sinusitis" ], "interventions": [ { "name": "6 day Prednisone", "type": "DRUG" }, { "name": "Augmentin", "type": "DRUG" }, { "name": "21 day Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 24, "start_date": "2015-08", "completion_date": "2019-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02927834" }, { "nct_id": "NCT03357614", "title": "Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infections" ], "interventions": [ { "name": "Sulopenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1395, "start_date": "2018-09-18", "completion_date": "2019-12-14", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 15, "location_summary": "Bellflower, California • Chula Vista, California • La Mesa, California + 11 more", "locations": [ { "city": "Bellflower", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03357614" }, { "nct_id": "NCT02891915", "title": "Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Cefdinir", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "6 Months to 71 Months" }, "enrollment_count": 385, "start_date": "2016-12-02", "completion_date": "2019-12-16", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Louisville, Kentucky + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02891915" }, { "nct_id": "NCT01069900", "title": "Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Intraabdominal Infections" ], "interventions": [ { "name": "Moxifloxacin (Avelox, BAY12-8039)", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Amoxicillin/Clavulanate", "type": "DRUG" }, { "name": "Moxifloxacin placebo", "type": "DRUG" }, { "name": "Ertapenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/Clavulanate placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Months to 17 Years" }, "enrollment_count": 458, "start_date": "2010-07-21", "completion_date": "2015-01-21", "has_results": true, "last_update_posted_date": "2018-03-20", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 2, "location_summary": "San Diego, California • Springfield, Massachusetts", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Springfield", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01069900" }, { "nct_id": "NCT00377260", "title": "Acute Otitis Media (AOM) Therapy Trial in Young Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "6 Months to 23 Months" }, "enrollment_count": 291, "start_date": "2006-11", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00377260" }, { "nct_id": "NCT01110382", "title": "A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Abscess, Intra-Abdominal", "Abdominal Abscess", "Abdomen, Acute", "Abdominal Pain", "Appendicitis", "Rupture", "Infection", "Intestinal Perforation", "Peritonitis", "Ileus" ], "interventions": [ { "name": "Doripenem", "type": "DRUG" }, { "name": "Meropenem placebo", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 41, "start_date": "2010-12", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 4, "location_summary": "San Diego, California • Washington D.C., District of Columbia • Cleveland, Ohio + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Toledo", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110382" }, { "nct_id": "NCT00797108", "title": "A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumonia, Bacterial" ], "interventions": [ { "name": "Sulopenem and PF-03709270", "type": "DRUG" }, { "name": "Ceftriaxone and amoxicillin/clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2009-01", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2016-03-10", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 12, "location_summary": "Chula Vista, California • Oceanside, California • Moline, Illinois + 4 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Moline", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00797108" }, { "nct_id": "NCT05846399", "title": "CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cat Bite", "Hand Injuries", "Arm Injury", "Infection, Bacterial", "Anti-bacterial Agents" ], "interventions": [ { "name": "Amoxicillin/clavulanate", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Placebo (microcrystalline cellulose)", "type": "OTHER" }, { "name": "Wound management", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2023-09-07", "completion_date": "2027-08-01", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-10-02T01:16:44.869Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846399" } ] }